These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26088113)

  • 21. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing cardiometabolic risk during treatment with antipsychotic medications.
    Amiel JM; Mangurian CV; Ganguli R; Newcomer JW
    Curr Opin Psychiatry; 2008 Nov; 21(6):613-8. PubMed ID: 18852570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
    Newcomer JW
    J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs.
    Hasnain M; Fredrickson SK; Vieweg WV
    J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
    Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
    J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the evidence for the use of metformin in the treatment of metabolic syndrome caused by antipsychotics.
    Jesus C; Jesus I; Agius M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S489-91. PubMed ID: 26417824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A "glucose eater" drug as a therapeutic agent in psychiatry.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2013 Sep; 51(9):13-6. PubMed ID: 23938069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders.
    Geoffroy PA; Etain B; Franchi JA; Bellivier F; Ritter P
    Curr Pharm Des; 2015; 21(23):3352-8. PubMed ID: 26088111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.
    Federico A; Zulli C; de Sio I; Del Prete A; Dallio M; Masarone M; Loguercio C
    World J Gastroenterol; 2014 Dec; 20(45):16841-57. PubMed ID: 25492998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More than half of UK prescriptions for antipsychotics are for non-severe mental illnesses.
    Kmietowicz Z
    BMJ; 2014 Dec; 349():g7758. PubMed ID: 25533316
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.
    Heal DJ; Gosden J; Smith SL
    Br J Clin Pharmacol; 2009 Dec; 68(6):861-74. PubMed ID: 20002080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
    Scheen AJ
    Rev Med Liege; 1998 Nov; 53(11):646-50. PubMed ID: 9887653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of undertreated chronic medical illnesses in patients with severe mental disorders.
    Fagiolini A; Goracci A
    J Clin Psychiatry; 2009; 70 Suppl 3():22-9. PubMed ID: 19570498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes knowledge and its importance expands rapidly: diabetes update in clinical therapeutics.
    Ryan JG
    Clin Ther; 2013 Jan; 35(1):A1-2. PubMed ID: 23328272
    [No Abstract]   [Full Text] [Related]  

  • 39. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.